AMD Stock Joins Cash Flow Picks Trading Below Fair Value

Services sectors in the US and Eurozone are still growing, while inflation worries keep central banks cautious and bond yields volatile. That mix can reward companies with strong cash flow potential that are not fully reflected in their share prices. The Undervalued Stocks Based On Cash Flows screener hunts for exactly those situations. This article highlights three stocks from the screener that may merit a closer look now.

The three stocks below are just a starting sample, and the full screen has surfaced 812 more companies with cash flow profiles and valuation gaps that could be just as compelling. To identify and analyze the highest conviction fits for your portfolio, head straight to the Undervalued Stocks Based On Cash Flows screener.

Advanced Micro Devices is a global semiconductor company best known for its CPUs and GPUs, but its connection to this cash flow focused screener comes mainly from the Data Center segment, where EPYC server chips and Instinct AI accelerators serve hyperscalers and cloud providers. Data Center revenue is about US$22.2b, compared with US$11.8b from Client, US$3.6b from Gaming, and US$3.7b from Embedded, giving AMD a broad but data center tilted mix. The company is large cap, with a market value of roughly US$772.6b.

AMD is notable here because the Data Center and AI products that underpin its cash flow potential are already tied to real world deployments, from Helios rack scale systems to long term agreements with AI leaders like Anthropic and major cloud providers. Strong reported margins and a history of rapid earnings growth support the idea of growing free cash generation, while Simply Wall St’s DCF suggests the stock trades below estimated fair value. The catch is that expectations are very rich, competitors are intense, and AMD is leaning on external financing and heavy investment to fund capacity. If data center demand or execution slips, that valuation gap could close in the wrong direction, which is why the detailed cash flow story matters.

AMD’s cash rich data center story is accelerating, yet the market debate around its true valuation and execution risk is intense. Get the full context in the DCF valuation analysis for Advanced Micro Devices

Build your own cash flow and AI shortlist

Advanced Micro Devices and the other two stocks in this list all came from a single screener, but the real edge comes when you set the rules yourself. Use our flexible Screener to combine metrics like cash flows, valuation and risks into a watchlist that fits you, or start with any of our curated Investing Ideas.

Merck is a global healthcare company focused on human pharmaceuticals like cancer drug Keytruda and HPV vaccine Gardasil, which drive substantial, recurring cash flows that anchor its place in this cash flow focused screener. Human pharmaceutical products generate about US$59.6b of Merck’s roughly US$63b in annual revenue, with animal health adding about US$6.7b and the rest from smaller revenue lines. The company is a large cap stock with a market value of around US$376.4b.

Investors watching Merck are really weighing two stories at once. On one side are powerful cash engines such as Keytruda and Gardasil, a deep oncology pipeline, and recent Phase 3 melanoma data that could support new long term revenue streams. On the other side are real pressure points, including a one off US$15.9b loss, thinner net margins at 4.8%, high reported debt levels and the eventual loss of Keytruda exclusivity. The DCF view suggests Merck trades well below estimated fair value. The key question is whether those cash flows stay resilient enough to outweigh the risks and insider selling that has picked up in recent months.

Merck’s cash engines and pipeline potential could be masking a much bigger valuation gap than the market is pricing in. See how the DCF view, debt load and loss all fit together in the DCF valuation analysis for Merck

Rocket Lab is a space company that launches small rockets and builds satellites, which ties it directly to this cash flow focused screener through revenue that can be modeled from recurring launch services and space systems contracts. Most of its revenue, about US$544 million, comes from the Space Systems segment, with around US$225 million from Launch Services, so the business is currently more about satellite and spacecraft solutions than just rocket launches. The company has a market value of roughly US$43.4b.

Rocket Lab gives you exposure to the growing “space backbone” through both launch services and satellite platforms, with Electron launches, Neutron development, and an expanding government and defense contract backlog feeding into forecast cash flow growth. The stock sits well below Simply Wall St’s DCF estimate, yet still carries real risks, including ongoing losses, funding needs for Neutron and the Iridium acquisition, and meaningful recent insider selling and dilution. For investors who can tolerate volatility, the mix of recurring government work, record Space Systems revenue and the potential inflection toward profitability over the next few years makes Rocket Lab a stock that may warrant closer examination rather than a quick pass.

Rocket Lab’s effort to expand into a space infrastructure role, alongside a DCF that indicates a wide valuation gap, could be missing a crucial piece. Get the full story in the analysis report for Rocket Lab

Seeking Fresh Investing Alternatives Today

Fresh stock ideas do not stay under the radar for long. Some appear to be building quiet breakout momentum while attention lags. Before the crowd reacts and pricing shifts, consider acting sooner rather than later.

• Explore early momentum in quality names before they gain wider attention by reviewing the curated 17 high quality undiscovered gems that still sit under most investors’ radar.
• Target dependable income streams while yields remain elevated by scanning the hand picked 12 dividend fortresses that aim to keep payments flowing even when prices drop.
• Review the focused 39 power grid technology and infrastructure stocks to examine companies connected to infrastructure build outs and potential changes in cash flow while they may still be quietly building strength.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com